Ocular Hypertension Completed Phase 4 Trials for Latanoprost (DB00654)

Also known as: Hypertension Ocular / Intraocular pressure high / Intraocular hypertension / Intraocular pressure raised / Ocular Hypertension (OHT) / Ocular Hypertension (OH) / Hypertension, Ocular / Elevated Intraocular Pressure / Intraocular pressure increased / IOP increased / Raised IOP / Ocular tension increased / Tension ocular increased / Pressure intraocular increased / Increased intraocular pressure

DBCOND0074237 (Ocular Hypertension)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02017327Safety and Efficacy Assessment of Monoprost® in Comparison With Lumigan® 0.01 % and Lumigan® 0.03% Unit DoseTreatment
NCT02419508SIMBRINZA® Suspension BID as an Adjunctive to Prostaglandin Analogue (PGA)Treatment
NCT00647101A Study to Assess the Efficacy of 3 Months of Latanoprost Treatment in Reducing the Intraocular Pressure in Patients With Ocular Hypertension or Open-Angle GlaucomaTreatment
NCT00798759Examination of Ocular Surface Effects With Administration of Travatan Z and XALATANTreatment
NCT00539526Evaluation of Hyperemia With the Use of Ocular Prostaglandin AnaloguesTreatment
NCT00887029A 12 Week Comparison of DuoTrav and Xalacom in Open-Angle GlaucomaTreatment
NCT00541242Safety and Efficacy of Bimatoprost Compared With Latanoprost in Patients With Glaucoma or Ocular HypertensionTreatment
NCT00527592A Single Dose Comfort Comparison of Travatan Z in One Eye Versus Xalatan in the Opposite Eye in Patients With Primary Open-Angle Glaucoma or Ocular HypertensionTreatment
NCT00950690Efficacy and Tolerability of Xalatan in Patients
NCT00941525Central Corneal Thickness and 24-hour Fluctuation of Intraocular PressureBasic Science
NCT00847483Comparison of Latanoprost With Travoprost and Bimatoprost in Patients With Elevated IOP. A 12-Weeks, Masked Evaluator, Phase IV Multi-Center Study in the USTreatment
NCT00811564An Evaluation of the Fixed Combination Brimonidine Tartrate 0.2%/ Timolol Maleate 0.5% to Latanoprost 0.005% in Glaucoma or Ocular Hypertension SubjectsTreatment
NCT00735449Comparing Efficacy and Safety of Combigan With Timolol Adjunctive to Xalatan in Glaucoma or Ocular Hypertension SubjectsTreatment
NCT00708422Effects of Travatan Z and Xalatan on Ocular Surface HealthTreatment
NCT01975714Intraocular Pressure and Tolerability Study of Preservative-free Prostaglandins (Bimatoprost and Latanoprost) on Glaucoma and Ocular Hypertension: European, Multicentric, Investigator-led, Single Masked StudyTreatment
NCT01937312Effect of SIMBRINZA® Suspension as an Added Therapy to a Prostaglandin AnalogueTreatment
NCT01253902Ocular Surface Tolerability Study of Prostaglandin Analogues in Patients With Open-Angle Glaucoma or Ocular HypertensionTreatment
NCT01263444Safety and Efficacy of Adding AZARGA® Adjunctive to Prostaglandin TherapyTreatment
NCT0165575824-hour Control of Intraocular Pressure (IOP) in Ocular HypertensionTreatment
NCT01525173A Safety and Efficacy Study of ALPHAGAN® P and LUMIGAN® in Subjects Previously Treated With Latanoprost for Glaucoma and Ocular HypertensionTreatment
NCT00140062Efficacy And Safety Of Xalatan Compared To Usual Care In Patients With Open Angle Glaucoma Or Ocular Hypertension.Treatment
NCT00140049A 12week, Randomized, Evaluator-Masked, Parallel Group Comparing Evening Dosing Of Xalacom Vs Cosopt In Subj W/ GlaucomaTreatment
NCT00143208Evaluation Of Intraocular Pressure Lowering-Effect Of Xalacom In Patients With Poag Or Oh.Treatment
NCT01162603Latanoprost Versus Tafluprost: 24-hour Intraocular Pressure (IOP)Treatment
NCT00440141Brimonidine 0.1% Versus Brinzolamide 1% as Adjunctive Therapy to Latanoprost 0.005%Treatment
NCT0033057724-Hour Intraocular Pressure (IOP) And Blood Pressure Control In Glaucoma And Ocular Hypertension PatientsTreatment
NCT00329095An Evaluation of Use of Topical Ocular Hypotensive Medication by ComplianceDiagnostic
NCT00304785Latanoprost Versus FotilTreatment
NCT00273429Cosopt Versus XalatanTreatment
NCT00273481Cosopt Versus XalacomTreatment